Hospital
Alta Los Angeles Hospitals, INC.
Alta Los Angeles Hospitals, INC. was paid $5.42M by Medicaid between Jan 2018 and Dec 2024, across 114 billing codes. Its largest line is 0131, Inj, acetaminophen (hikma) — 23% of everything it billed.
33Billing provider infoALTA LOS ANGELES HOSPITALS, INC.
LOS ANGELES, CA 90023
LOS ANGELES, CA 90023
33aNPI1922001809assigned 05/24/2005
33bProvider typePsychiatric Hospital Unit
28Total paid$5.42M
24GClaims199,866
24DCodes billed114
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in California
Rank by total paid#10 of 33
Median peer was paid$361K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ELDERS, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,301 | $636K | |
| 2019 | 30,519 | $649K | |
| 2020 | 25,271 | $507K | |
| 2021 | 24,715 | $874K | |
| 2022 | 33,571 | $1.53M | |
| 2023 | 28,031 | $858K | |
| 2024incomplete | 20,458 | $372K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0131 | Inj, acetaminophen (hikma) | 23% | 505 | 486 | $1.26M |
| 0450 | Emergency room services | 20% | 24,255 | 22,623 | $1.10M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.9% | 8,022 | 7,439 | $373K |
| 0209 | 6.1% | 348 | 335 | $333K | |
| 0360 | 3.6% | 1,897 | 1,722 | $197K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 3,941 | 3,615 | $150K |
| Z7502 | 2.5% | 3,691 | 3,640 | $137K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 1,346 | 1,300 | $121K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.1% | 2,213 | 2,070 | $115K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 10,258 | 9,514 | $105K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 2,162 | 2,065 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 15,311 | 13,981 | $100K |
102 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 925 | $82K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 7,231 | $82K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 1,312 | $76K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 4,060 | $76K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 3,376 | $63K |
| 99199 | Unlisted special service, procedure or report | 1.1% | 1,939 | $62K |
| 80053 | Comprehensive metabolic panel | 1.0% | 4,720 | $56K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.0% | 1,210 | $54K |
| 0250 | <1% | 5,348 | $50K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,170 | $44K |
| 84484 | <1% | 6,044 | $44K | |
| 0710 | <1% | 2,522 | $43K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,453 | $42K |
| 0121 | <1% | 12 | $38K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,119 | $33K |
| J3490 | Unclassified drugs | <1% | 4,644 | $32K |
| 83880 | <1% | 1,398 | $28K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,828 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,540 | $23K |
| 81025 | <1% | 4,734 | $22K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,386 | $22K |
| 99285 | Emergency room visit (most serious) | <1% | 206 | $22K |
| 0760 | <1% | 351 | $20K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,146 | $19K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,574 | $19K |
| 83690 | <1% | 3,366 | $17K | |
| 85730 | <1% | 3,715 | $16K | |
| 81001 | <1% | 6,117 | $16K | |
| 83605 | <1% | 1,830 | $15K | |
| 87040 | <1% | 1,310 | $14K | |
| 99283 | Emergency room visit (moderate) | <1% | 215 | $13K |
| 82550 | <1% | 2,524 | $11K | |
| 85610 | <1% | 3,794 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,791 | $11K |
| 99284 | Emergency room visit (serious) | <1% | 205 | $10K |
| 81003 | <1% | 6,096 | $10K | |
| 80076 | <1% | 1,342 | $9K | |
| 87088 | <1% | 1,680 | $9K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,546 | $8K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 70 | $7K |
| 82150 | <1% | 1,413 | $7K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 233 | $6K |
| 86328 | <1% | 171 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 318 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 715 | $4K |
| 0270 | <1% | 1,972 | $4K | |
| 82948 | <1% | 392 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 412 | $4K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 134 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 438 | $4K |
| 87077 | <1% | 481 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 364 | $3K |
| 87186 | <1% | 217 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 79 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 576 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 321 | $2K |
| 82140 | <1% | 190 | $2K | |
| 99406 | <1% | 153 | $2K | |
| 74018 | <1% | 115 | $1K | |
| 82553 | <1% | 176 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 108 | $1K |
| 84703 | <1% | 210 | $927.42 | |
| 71010 | <1% | 64 | $893.40 | |
| 72100 | <1% | 41 | $865.83 | |
| 73560 | <1% | 51 | $808.94 | |
| 0361 | <1% | 12 | $803.94 | |
| Z7610 | <1% | 57 | $726.05 | |
| 88312 | <1% | 115 | $616.82 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $454.88 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 105 | $400.50 |
| 94644 | <1% | 25 | $381.36 | |
| 86140 | <1% | 94 | $378.84 | |
| 80061 | Lipid panel | <1% | 41 | $349.66 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 117 | $324.17 |
| 87420 | <1% | 62 | $282.64 | |
| 85651 | <1% | 117 | $252.75 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 54 | $218.26 |
| 83735 | <1% | 40 | $207.03 | |
| A4649 | Surgical supply; miscellaneous | <1% | 182 | $187.81 |
| 85378 | <1% | 26 | $164.36 | |
| 87338 | <1% | 28 | $155.10 | |
| 73120 | <1% | 13 | $122.74 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 12 | $121.66 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 24 | $91.41 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $68.22 |
| 0324 | <1% | 559 | $43.05 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 12 | $38.70 |
| 0636 | <1% | 940 | $30.27 | |
| 87081 | <1% | 14 | $27.06 | |
| 0370 | 0% | 135 | $0.00 | |
| 0307 | 0% | 358 | $0.00 | |
| 0305 | 0% | 1,007 | $0.00 | |
| 0306 | 0% | 693 | $0.00 | |
| 0301 | 0% | 1,012 | $0.00 | |
| 0420 | 0% | 190 | $0.00 | |
| 0258 | 0% | 63 | $0.00 | |
| 0300 | 0% | 1,014 | $0.00 | |
| 0730 | 0% | 268 | $0.00 | |
| 0320 | 0% | 74 | $0.00 | |
| 0402 | 0% | 91 | $0.00 | |
| 0302 | 0% | 117 | $0.00 | |
| 0483 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELDERS, ROBERT (SECRETARY)
Parent organizationALTA HOSPITALS SYSTEM, LLC
| Provider | Location | Paid |
|---|---|---|
| Prospect Waterbury, INC. | Waterbury, CT | $84.62M |
| Prospect Manchester Hospital, INC. | Manchester, CT | $69.20M |
| Prospect Chartercare RWMC, LLC | Providence, RI | $57.10M |
| Prospect CCMC, LLC | Chester, PA | $40.89M |
| Prospect CT Medical Foundation, INC. | Manchester, CT | $34.07M |
| Prospect Rockville Hospital, INC. | Vernon, CT | $30.06M |
| Prospect Chartercare Sjhsri, LLC | North Providence, RI | $10.94M |
| Prospect DCMH, LLC | Drexel Hill, PA | $10.37M |
| Prospect CCMC, LLC | Chester, PA | $5.46M |
| Prospect CCMC, LLC | Chester, PA | $5.03M |
| Prospect CCMC, LLC | Chester, PA | $3.71M |
| Prospect Chartercare Physicians, LLC | Cranston, RI | $2.31M |
| Prospect Echn Home Health, INC. | Vernon, CT | $1.75M |
| Prospect Waterbury Home Health, INC. | Watertown, CT | $1.30M |
| Prospect Health Access Network, INC. | Chester, PA | $1.22M |
| Alta Newport Hospital, LLC | Tustin, CA | $1.16M |
| Prospect Health Access Network, INC. | Crum Lynne, PA | $924K |
| Prospect Health Access Network, INC. | Chester, PA | $872K |
| Prospect Chartercare Sjhsri, LLC | North Providence, RI | $858K |
| Prospect Health Access Network, INC. | Drexel Hill, PA | $815K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.